Personal information

Activities

Collapse all

Employment (4)

UAB Exolitus: Kaunas, LT

2020-02-12 to present | CEO
Employment
Source: Self-asserted source
Aiste Jekabsone

Lithuanian University of Health Sciences: Kaunas, LT

2019 to present | Senior scientist (Cardiology Institute, Preclinical Research Laboratory for Medicinal Products)
Employment
Source: Self-asserted source
Aiste Jekabsone

Lithuanian University of Health Sciences: Kaunas, LT

2017 to present | Senior scientist, Head (Institute of Pharmaceutical Technologies, Laboratory of Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Aiste Jekabsone

Lithuanian University of Health Sciences: Kaunas, LT

1997 to 2002 | Scientist (Neuroscience Institute, Laboratory of Biochemistry)
Employment
Source: Self-asserted source
Aiste Jekabsone

Education and qualifications (2)

University of Cambridge: Cambridge, Cambridgeshire, GB

2004-11-17 to 2006-11-19 | PostDoc (Biochemistry Department)
Education
Source: Self-asserted source
Aiste Jekabsone

Lithuanian University of Health Sciences: Kaunas, LT

1998-09-10 to 2002-07-10 | PhD
Education
Source: Self-asserted source
Aiste Jekabsone

Professional activities (5)

Lithuanian Association of Stem Cell Researchers: Vilnius, LT

Membership
Source: Self-asserted source
Aiste Jekabsone

Baltic Society of Exctracellular Vesicles: Tartu, EE

2022 to present
Membership
Source: Self-asserted source
Aiste Jekabsone

Lithuanian Physiology Society: Kaunas, LT

2016 to present
Membership
Source: Self-asserted source
Aiste Jekabsone

Lithuanian Neuroscience Association: Vilnius, LT

2014 to present
Membership
Source: Self-asserted source
Aiste Jekabsone

Lithuanian Biochemical Society: Vilnius, LT

1997 to present
Membership
Source: Self-asserted source
Aiste Jekabsone

Funding (26)

LSMU-Heidelberg University Clinics research project "The role of mitochondria and extracellular vesicles in cardiomyocyte pathologies caused by ischemia and cancer treatment"

2022 to 2022 | Grant
Baltic-German University Liaison Office (Riga, LV)
GRANT_NUMBER:

2022/11
Source: Self-asserted source
Aiste Jekabsone

ExoPlant, „Environmental and genotype impacts on plant exosome characteristics and potential applications for cosmetics and pharmacy“

2021 to 2024 | Grant
Research Council of Lithuania (Vilnius, LT)
Source: Self-asserted source
Aiste Jekabsone

Design of functional fish feed additives from wild algal biomass

2021 to 2023 | Grant
Agency for Science, Innovation and Technology (MITA) (Vilnius, LT)
Part of GRANT_NUMBER:

project E!13474
Source: Self-asserted source
Aiste Jekabsone

TerpenCoTech, "Control of Targeted Metabolites of Hemp for Development of Products to Alleviate COVID-19 Symptoms,"

2021 to 2023 | Grant
Lietuvos Mokslo Taryba (Vilnius, LT)
GRANT_NUMBER:

01.2.2-LMT-K-718-05-0039
Source: Self-asserted source
Aiste Jekabsone

cTECH, "Technology for the management of cardiovascular mitochondrial dysfunction caused by COVID-19"

2021 to 2022 | Grant
Lietuvos Mokslo Taryba (Vilnius, LT)
GRANT_NUMBER:

13.1.1-LMT-K-718-05-0029
Source: Self-asserted source
Aiste Jekabsone

ESELEKT „Improvement of exosome selectivity to cardiomyocytes“

2021 to 2022 | Grant
Agency for Science, Innovation, and Technology (Vilnius, LT)
GRANT_NUMBER:

31V-43
Source: Self-asserted source
Aiste Jekabsone

The effect of stem cell exosomes on energetic metabolism of cardiomyocytes affected by hypoxia

2021 to 2022 | Grant
Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

09.3.3-LMT-K-712-25-0223
Source: Self-asserted source
Aiste Jekabsone

"Development of compounds with high efficiency against S. aureus based on in silico chemogenomics, in vitro and in vivo studies"

2020 to 2022 | Grant
Lithuanian Business Support Agency (Vilnius, LT)
GRANT_NUMBER:

01.2.1-LVPA-K-856

Source: Self-asserted source
Aiste Jekabsone

Investigation of the effect of growth factors on skin cells

2019-04 to 2019-12 | Contract
Innovative Pharma Baltics, UAB (Vilnius, LT)
GRANT_NUMBER:

PR19-77
Source: Self-asserted source
Aiste Jekabsone

Functionalisation of extracellular vesicles for targeted delivery to glioblastoma cells

2019 to 2023 | Grant
Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

KD-19232
Source: Self-asserted source
Aiste Jekabsone

Adaptation of tissue mimetics for in vitro melanoma model design and drug efficiency testing

2019 to 2020 | Contract
Agency for Science, Innovation and Technology of (Vilnius, LT)
Part of GRANT_NUMBER:

01.2.1-MITA-T-851
Source: Self-asserted source
Aiste Jekabsone

The effect of exosomes from Poly (I:C)-primed airway epithelium on brain cell immuno-metabolism

2019 to 2020 | Grant
Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

09.3.3-LMT-K-712-PRM19-208
Source: Self-asserted source
Aiste Jekabsone

EXOTARGET “Exosome application for targeted drug delivery

2018 to 2022 | Grant
Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

01.2.2-LMT-K-718-01-0036
Source: Self-asserted source
Aiste Jekabsone

Functional drink with activity-specified electrolyte composition design

2018 to 2021 | Contract
Lithuanian Business Support Agency (Vilnius, LT)
Part of GRANT_NUMBER:

J05-LVPA-K-01-0220
Source: Self-asserted source
Aiste Jekabsone

Functional food with encapsulated bioactive substances design

2018 to 2021 | Contract
Lithuanian Business Support Agency (Vilnius, LT)
Part of GRANT_NUMBER:

J05-LVPA-K-01-024
Source: Self-asserted source
Aiste Jekabsone

Engineering and functionalization of delivery system with Pelargonium sidoides biologically active substance on inflamed periodontal surface area", PELARGODONT

2017 to 2019 | Grant
Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

S-M-ERA.NET-17-2
Source: Self-asserted source
Aiste Jekabsone

Modulation of neuronal-glial cell behavior by collagen mimetic peptide hydrogels

2016-09 to 2016-12 | Contract
Agency for Science, Innovation and Technology (Vilnius, LT)
GRANT_NUMBER:

31V-32/PRM16-36
Source: Self-asserted source
Aiste Jekabsone

Design, visualization and analysis of in vitro tissue mimetics

2016-02 to 2016-08 | Contract
Ferentis, UAB (Vilnius, LT)
GRANT_NUMBER:

PR16-82
Source: Self-asserted source
Aiste Jekabsone

Investigation of cell interaction with prototypical hydrogel samples

2014-02 to 2014-11 | Contract
Lithuanian Business Support Agency (Vilnius, LT)
GRANT_NUMBER:

VP2-1.3-ŪM-02-K-04-016
Source: Self-asserted source
Aiste Jekabsone

The role of mitochondria, nitric oxide and cytochrome c reducing compounds preventing ischemic damage of myocardium and brain

2014 to 2015 | Grant
Research Council of Lithuania (Vilnius, LT)
Part of GRANT_NUMBER:

VP1-3.1-ŠMM-07-K-01-130
Source: Self-asserted source
Aiste Jekabsone

Molecular mechanisms of pathogenesis of Alzheimer's disease (MALPAMA)

2013 to 2014 | Grant
Research Council of Lithuania (Vilnius, LT)
Part of GRANT_NUMBER:

LIG-04/2012
Source: Self-asserted source
Aiste Jekabsone

The role of mitochondria in neuronal damage induced by ischemia/reperfusion and beta-amyloid peptide

2007 to 2008 | Grant
Lithuanian State Science and Studies foundation (Vilnius, LT)
GRANT_NUMBER:

T-80/07
Source: Self-asserted source
Aiste Jekabsone

Mitochondria and beta-amyloid in brain ischemia/reperfusion, (Mitochondria & Abeta)

2006 to 2007 | Grant
EC (Brussells, BE)
GRANT_NUMBER:

MERG-CT-2006-44907
Source: Self-asserted source
Aiste Jekabsone

Investigation of protective estrogen effect in ischemic myocardium

2004 to 2005 | Grant
Lithuanian State Science and Studies foundation (Vilnius, LT)
Part of GRANT_NUMBER:

T-35/04
Source: Self-asserted source
Aiste Jekabsone

The role of estrogens and NO preventing mitochondrial damage induced by myocardial ischemia

2003 to 2004 | Grant
Lithuanian State Science and Studies foundation (Vilnius, LT)
GRANT_NUMBER:

T-18
Source: Self-asserted source
Aiste Jekabsone

The role of mitochondria in apoptosis initiation

1998 to 1999 | Grant
Lithuanian State Science and Studies foundation (Vilnius, LT)
GRANT_NUMBER:

299
Source: Self-asserted source
Aiste Jekabsone

Peer review (9 reviews for 5 publications/grants)

Review activity for Cells. (2)
Review activity for International journal of molecular sciences. (4)
Review activity for Journal of extracellular biology. (1)
Review activity for Medical sciences. (1)
Review activity for Neurotoxicity research. (1)
How many people are using ORCID?